EDIT
Price
$3.06
Change
+$0.20 (+6.99%)
Updated
Jul 10 closing price
Capitalization
257.84M
19 days until earnings call
TGTX
Price
$37.67
Change
-$0.25 (-0.66%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
6.02B
25 days until earnings call
Interact to see
Advertisement

EDIT vs TGTX

Header iconEDIT vs TGTX Comparison
Open Charts EDIT vs TGTXBanner chart's image
Editas Medicine
Price$3.06
Change+$0.20 (+6.99%)
Volume$2.56M
Capitalization257.84M
TG Therapeutics
Price$37.67
Change-$0.25 (-0.66%)
Volume$28.8K
Capitalization6.02B
EDIT vs TGTX Comparison Chart in %
Loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDIT vs. TGTX commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a StrongBuy and TGTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (EDIT: $3.06 vs. TGTX: $37.92)
Brand notoriety: EDIT and TGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 106% vs. TGTX: 86%
Market capitalization -- EDIT: $257.84M vs. TGTX: $6.02B
EDIT [@Biotechnology] is valued at $257.84M. TGTX’s [@Biotechnology] market capitalization is $6.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 0 FA rating(s) are green whileTGTX’s FA Score has 1 green FA rating(s).

  • EDIT’s FA Score: 0 green, 5 red.
  • TGTX’s FA Score: 1 green, 4 red.
According to our system of comparison, TGTX is a better buy in the long-term than EDIT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 3 TA indicator(s) are bullish while TGTX’s TA Score has 6 bullish TA indicator(s).

  • EDIT’s TA Score: 3 bullish, 3 bearish.
  • TGTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TGTX is a better buy in the short-term than EDIT.

Price Growth

EDIT (@Biotechnology) experienced а +19.07% price change this week, while TGTX (@Biotechnology) price change was +4.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

EDIT is expected to report earnings on Nov 10, 2025.

TGTX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGTX($6.02B) has a higher market cap than EDIT($258M). EDIT YTD gains are higher at: 140.945 vs. TGTX (25.149). TGTX has higher annual earnings (EBITDA): 70.5M vs. EDIT (-244.52M). EDIT has more cash in the bank: 221M vs. TGTX (132M). TGTX has less debt than EDIT: TGTX (8.98M) vs EDIT (31.1M). TGTX has higher revenues than EDIT: TGTX (386M) vs EDIT (35.8M).
EDITTGTXEDIT / TGTX
Capitalization258M6.02B4%
EBITDA-244.52M70.5M-347%
Gain YTD140.94525.149560%
P/E RatioN/A150.68-
Revenue35.8M386M9%
Total Cash221M132M167%
Total Debt31.1M8.98M346%
FUNDAMENTALS RATINGS
EDIT vs TGTX: Fundamental Ratings
EDIT
TGTX
OUTLOOK RATING
1..100
2456
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
89
Overvalued
PROFIT vs RISK RATING
1..100
10068
SMR RATING
1..100
9946
PRICE GROWTH RATING
1..100
3548
P/E GROWTH RATING
1..100
1008
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EDIT's Valuation (44) in the Biotechnology industry is somewhat better than the same rating for TGTX (89). This means that EDIT’s stock grew somewhat faster than TGTX’s over the last 12 months.

TGTX's Profit vs Risk Rating (68) in the Biotechnology industry is in the same range as EDIT (100). This means that TGTX’s stock grew similarly to EDIT’s over the last 12 months.

TGTX's SMR Rating (46) in the Biotechnology industry is somewhat better than the same rating for EDIT (99). This means that TGTX’s stock grew somewhat faster than EDIT’s over the last 12 months.

EDIT's Price Growth Rating (35) in the Biotechnology industry is in the same range as TGTX (48). This means that EDIT’s stock grew similarly to TGTX’s over the last 12 months.

TGTX's P/E Growth Rating (8) in the Biotechnology industry is significantly better than the same rating for EDIT (100). This means that TGTX’s stock grew significantly faster than EDIT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EDITTGTX
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GVDNY96.830.07
+0.07%
Givaudan SA
HKCVF0.67N/A
N/A
HK Electric Investments & HK Electric Investments Ltd.
DPBSF32.00N/A
N/A
Dampskibsselskabet Norden A/S
PTRRF0.03N/A
N/A
Pointerra Ltd.
AIMLF0.04N/A
-8.50%
AI / ML Innovations Inc.

TGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with ARRY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then ARRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
-0.66%
ARRY - TGTX
36%
Loosely correlated
-0.78%
CLLS - TGTX
36%
Loosely correlated
+1.54%
AXON - TGTX
36%
Loosely correlated
-9.04%
ROIV - TGTX
36%
Loosely correlated
+3.12%
CPRX - TGTX
36%
Loosely correlated
+1.04%
More